Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LOXO-338 by Loxo Oncology for Follicular Lymphoma: Likelihood of Approval
LOXO-338 is under clinical development by Loxo Oncology and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...
Data Insights
LOXO-338 by Loxo Oncology for B-Cell Chronic Lymphocytic Leukemia: Likelihood of Approval
LOXO-338 is under clinical development by Loxo Oncology and currently in Phase I for B-Cell Chronic Lymphocytic Leukemia. According to...